Pharmaceuticals Sector - Solvay

Key fi gures [EUR million]
Chemicals Sector
2003 2004 2005
Sales 2 386 2 433 2 785
REBIT 182 180 285
Depreciation 172 174 173
Capital expenditure 182 165 261
R&D 30 27 27
Headcount [1] 9 203 8 594 8 721
Sales
breakdown 2005:
EUR 2 785 million
[1] Full-time equivalents at January 1 of the following year
Sales by customer
segment 2005:
EUR 2 785 million
By cluster and SBU
g Minerals cluster 44%
37 % Carbonates
4 % Barium Strontium
3 % Advanced Functional Minerals
g Electrochemicals and
Fluorinated Products cluster 39%
25 % Electrochemicals
14 % Fluorinated Products
g Oxygen cluster 17%
11 % Hydrogen peroxide
4 % Detergents
2 % Caprolactones
By geographic area
g Europe
59 % European Union (25)
5 % Other European countries
g Asia-Pacifi c
g The Americas
17 % Nafta
8 % Mercosur
g Rest of the world
By customer segment
Chemical industry 23%
Glass industry 21%
Detergents, cleaning and
hygiene products 11%
Paper 9%
Construction and architecture 4%
Water and environment 4%
Human and animal
food processing 3%
Automobile industry 2%
Human health 2%
Electricity and electronics 1%
Consumer goods 1%
Other industries 19%
14 %
11 %
25 %
7 %
4 %
25 %
19 %
3 %
4 %
4 %
9 %
4 %
2 %
11 %
37 %
4 %
3 %
64 %
23 2 %
21 %
Vincent De Cuyper et Christian Jourquin
Good results in a time
of expensive energy
All our Strategic Business Units
are energy consumers.
As such, they have been exposed
to the general rise in gas and
electricity prices, but to a lesser
degree thanks to our cogeneration
units, our technological leadership
in manufacturing processes, our
well-performing manufacturing
infrastructure and a strategy
of medium- to long-term hedging
of energy purchases.
Depending on each SBU’s
particular market conditions, price
increases have been negotiated
with our customers.
25
Solvay Global Annual Report 2005
Chemicals